STK33
Serine/threonine-protein kinase 33
Also known as: STK33_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BYT3
- Gene
- STK33
- Ensembl
- ENSG00000130413
- Chromosome
- 11
- Canonical length
- 514 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Cytosol,Flagellar centriole,Mid piece
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Enables protein serine/threonine kinase activity. Involved in spermatogenesis. Predicted to be located in manchette. Predicted to be active in nucleus. Implicated in colorectal cancer; depressive disorder; and spermatogenic failure 93. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
514 residues, UniProt reviewed canonical sequence.
>Q9BYT3|STK33
1 MADSGLDKKS TKCPDCSSAS QKDVLCVCSS KTRVPPVLVV EMSQTSSIGS AESLISLERK
61 KEKNINRDIT SRKDLPSRTS NVERKASQQQ WGRGNFTEGK VPHIRIENGA AIEEIYTFGR
121 ILGKGSFGIV IEATDKETET KWAIKKVNKE KAGSSAVKLL EREVNILKSV KHEHIIHLEQ
181 VFETPKKMYL VMELCEDGEL KEILDRKGHF SENETRWIIQ SLASAIAYLH NNDIVHRDLK
241 LENIMVKSSL IDDNNEINLN IKVTDFGLAV KKQSRSEAML QATCGTPIYM APEVISAHDY
301 SQQCDIWSIG VVMYMLLRGE PPFLASSEEK LFELIRKGEL HFENAVWNSI SDCAKSVLKQ
361 LMKVDPAHRI TAKELLDNQW LTGNKLSSVR PTNVLEMMKE WKNNPESVEE NTTEEKNKPS
421 TEEKLKSYQP WGNVPDANYT SDEEEEKQST AYEKQFPATS KDNFDMCSSS FTSSKLLPAE
481 IKGEMEKTPV TPSQGTATKY PAKSGALSRT KKKLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against STK33 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 45 nTPM
Expression across tissuesHPA
Tissue
- testis: 45 nTPM
- choroid plexus: 38 nTPM
- fallopian tube: 33 nTPM
- pituitary gland: 20 nTPM
- parathyroid gland: 18 nTPM
- thyroid gland: 16 nTPM
Single-cell type
- respiratory ciliated cells: 2,155 nCPM
- corticotrophs: 1,775 nCPM
- choroid plexus epithelial cells: 1,464 nCPM
- ependymal cells: 1,208 nCPM
- fallopian tube ciliated cells: 1,056 nCPM
- endometrial ciliated cells: 1,020 nCPM
Immune cell
- memory B-cell: 3.4 nTPM
- naive B-cell: 2 nTPM
- memory CD8 T-cell: 0.6 nTPM
- naive CD8 T-cell: 0.5 nTPM
- plasmacytoid DC: 0.3 nTPM
- gdT-cell: 0.2 nTPM
Brain region
- choroid plexus: 79 nTPM
- midbrain: 27 nTPM
- medulla oblongata: 25 nTPM
- hypothalamus: 21 nTPM
- spinal cord: 20 nTPM
- thalamus: 16 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about STK33.
Disease | AllUniProt
Conditions STK33 is implicated in, by any mechanism.
- Spermatogenic failure 93 (SPGF93) MIM:620849
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 100 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Spermatogenic failure 93
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.86
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.49
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- manchette assembly
- mitotic DNA damage checkpoint signaling
- negative regulation of proteasomal ubiquitin-dependent protein catabolic process
- negative regulation of protein polyubiquitination
- protein autophosphorylation
- spermatogenesis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of STK33 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads STK33 as an antibody target. Whether an autoantibody or antibody against STK33 could matter depends on whether native STK33 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
STK33 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label STK33 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...